Research Article
Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo
Table 1
Clinical characteristics of study subjects.
| | | Group 1 (n = 52) | Group 2 (n = 50) | value |
| | Age (mean ± SD) | 32.71 ± 14.92 | 36.34 ± 10.34 | 0.22 |
| | Male, n (%) | 18 (34.62%) | 18(36%) | 0.88 |
| | Age of onset, n (%) | | ≤30 years | 29 (55.77%) | NA | NA | | >30 years | 23 (44.23%) | | |
| | Duration of disease, n (%) | | <5 years | 40 (76.92%) | NA | NA | | 5–10 years | 8 (15.39%) | | | | >10 years | 4 (7.69%) | | |
| | Family history of vitiligo, n (%) | 11 (21.15%) | NA | NA |
| | Affected body surface area, n (%) | | <3% | 32 (61.54%) | NA | NA | | 3–10% | 13 (25.00%) | | | | >10% | 7 (13.46%) | | |
| | Triggers, n (%) | | Trauma | 11 (21.15%) | NA | NA | | Psychological stress | 19 (36.54%) | | | | Sunburn | 6 (11.54%) | | | | Pregnancy | 6 (11.54%) | | |
| | Vitiligo activity, n (%) | | NA | NA | | Progressive | | | | | VIDA +4 | 23 (44.23%) | | | | VIDA +3 | 12 (23.08%) | | | | Stable | | | | | VIDA +2 | 7 (13.46%) | | | | VIDA +1 | 8 (15.39%) | | | | VIDA 0 | 0 (0.00%) | | | | VIDA −1 | 2 (3.84%) | | |
| | Clinical variants, n (%) | | NA | NA | | Focal | 11 (21.15%) | | | | Acro/acrofacial | 4 (7.69%) | | | | Mucosa | 1 (1.93%) | | | | Generalized | 36 (69.23%) | | | | Universal | 0 (0.00%) | | |
| | Lesion characteristics, n (%) | | NA | NA | | Trichrome | 31 (59.62%) | | | | Confetti-like | 10 (19.23%) | | | | Perifollicular hyperpigmentation | 22 (42.31%) | | | | Leukotrichia | 14 (26.92%) | | | | Koebner phenomenon | 12 (23.08%) | | | | Nevus halo | 2 (3.85%) | | |
|
|
NA, not available.
|
